Early Colostomy Reversal May Improve Outcomes
|
By HospiMedica International staff writers Posted on 17 Dec 2018 |
A new study suggests that in selected patients, colostomy closure following the Hartmann procedure for diverticulitis is safe as early as 45 days after the initial procedure.
Researchers at Yale School of Medicine (New Haven, CT, USA) conducted a retrospective analysis of inpatient databases for California, Florida, and Maryland in order to explore the association between colostomy reversal timing and operative outcomes in 1,660 patients (51.8% men, median age 61 years) who underwent the Hartmann procedure for diverticulitis. The patients were divided based on timing of colostomy reversal following the index surgery into early (45-110 days), middle (111-169 days), and late (≥170 days). Patients with readmissions between the index surgery and reversal were excluded.
The results revealed that the median time to reversal was 129 days. Patient characteristics associated with early reversal included being 60 years or younger, white, and having private insurance (compared to Medicaid). Mortality, transfusion, presence of ileus, and major complications were not significantly different among groups. However, prolonged length of stay and 90-day readmission was significantly more likely in the late timing groups. The study was published on November 21, 2018, in JAMA Surgery.
“Less than one-third of patients undergo colostomy reversal within one year after end colostomy for diverticulitis, and reversal timing is associated with socioeconomic disparities,” concluded senior author Kevin Pei, MD, and colleagues. “In selected patients with an uncomplicated course, improved outcomes are associated with earlier reversal, and colostomy reversal is safe as early as 45 to 110 days after the initial procedure.”
Hartmann's procedure, or proctosigmoidectomy, involves surgical resection of the rectosigmoid colon with closure of the anorectal stump and formation of a colostomy. It is the most common operation carried out by general surgeons for management of malignant obstruction of the distal colon. During the procedure, the lesion is removed, the distal bowel closed intraperitoneally, and the proximal bowel diverted with a stoma. The procedure is named after French surgeon Henri Albert Hartmann, who first described it in 1921.
Related Links:
Yale School of Medicine
Researchers at Yale School of Medicine (New Haven, CT, USA) conducted a retrospective analysis of inpatient databases for California, Florida, and Maryland in order to explore the association between colostomy reversal timing and operative outcomes in 1,660 patients (51.8% men, median age 61 years) who underwent the Hartmann procedure for diverticulitis. The patients were divided based on timing of colostomy reversal following the index surgery into early (45-110 days), middle (111-169 days), and late (≥170 days). Patients with readmissions between the index surgery and reversal were excluded.
The results revealed that the median time to reversal was 129 days. Patient characteristics associated with early reversal included being 60 years or younger, white, and having private insurance (compared to Medicaid). Mortality, transfusion, presence of ileus, and major complications were not significantly different among groups. However, prolonged length of stay and 90-day readmission was significantly more likely in the late timing groups. The study was published on November 21, 2018, in JAMA Surgery.
“Less than one-third of patients undergo colostomy reversal within one year after end colostomy for diverticulitis, and reversal timing is associated with socioeconomic disparities,” concluded senior author Kevin Pei, MD, and colleagues. “In selected patients with an uncomplicated course, improved outcomes are associated with earlier reversal, and colostomy reversal is safe as early as 45 to 110 days after the initial procedure.”
Hartmann's procedure, or proctosigmoidectomy, involves surgical resection of the rectosigmoid colon with closure of the anorectal stump and formation of a colostomy. It is the most common operation carried out by general surgeons for management of malignant obstruction of the distal colon. During the procedure, the lesion is removed, the distal bowel closed intraperitoneally, and the proximal bowel diverted with a stoma. The procedure is named after French surgeon Henri Albert Hartmann, who first described it in 1921.
Related Links:
Yale School of Medicine
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







